Asthma Research Review, Issue 1

In this issue:

Risankizumab in severe asthma
Long-term effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma
Risk of serious COVID-19 outcomes among adults with asthma
Long-term safety and efficacy of dupilumab
Oral corticosteroid elimination in adults with severe, eosinophilic asthma
Quantitative comparison of dose-effect and time-course of fluticasone
Positioning as-needed budesonide-formoterol for mild asthma
Stopping versus continuing long-term mepolizumab
Accelerated decline in lung function in adults
Overuse of oral corticosteroids

Please login below to download this issue (PDF)

Subscribe